Cardioprotective mechanism of omega-3 polyunsaturated fatty acids

Slides:



Advertisements
Similar presentations
Omega-3 Fatty Acids and Immunity By Jostelo Garces.
Advertisements

EICOSANOIDS (prostaglandins, thromboxanes, leukotrienes)
Long chain polyunsaturated fatty acids and inflammation
Date of download: 6/2/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Fatty Acids and Cardiovascular Disease: Effects.
Acute myocardial infarction as presentation of an infiltrative lung neoplasia Aitor Uribarri, MD, Adolfo Villa, MD, Gerard Loughlin, MD, Francisco Fernández-Avilés,
The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.
Prolonged survival after surgery for cardiac metastasis from malignant melanoma Antoine Noel, intern, Claire Toquet, MD, Jacques Dewilde, MD Journal of.
Radiofrequency catheter ablation of incessant atrial tachycardia in pregnant women with minimal radiation exposure: Lessons from two case studies Pil-Sung.
Eicosapentaenoic Acid Eicosapentaenoic acid Eicosapentaenoic acid (EPA) is an omega-3 fatty acid.
Volume 29, Issue 1, Pages 1-7 (January 2013)
Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements 
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Mechanism of Action of Colchicine in the Treatment of Gout
Volume 64, Issue 3, Pages (September 2014)
Fatty acids, inflammation, and asthma
Lipids in Liver Disease: Looking Beyond Steatosis
The inflammasome in liver disease
Therapy of autoinflammatory syndromes
Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases
Thoetchai (Bee) Peeraphatdit, Douglas A. Simonetto, Vijay H. Shah 
Matthew Spite, Joan Clària, Charles N. Serhan  Cell Metabolism 
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease 
Adam J. Byrne, Toby M. Maher, Clare M. Lloyd 
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease 
New class of anti-inflammatory agents for colonic epithelial cells
Treatment prospects for autosomal-dominant polycystic kidney disease
Omega 3 – Omega 6: What is right for the liver?
Hal M. Hoffman, MD, Lori Broderick, MD, PhD 
Nat. Rev. Rheumatol. doi: /nrrheum
Christopher D. Buckley, Derek W. Gilroy, Charles N. Serhan  Immunity 
Ding Ai, John Y.-J. Shyy, Yi Zhu  Kidney International 
Distribution of Bioactive Lipid Mediators in Human Skin
Abrogated cardio protective effect of ischemic preconditioning in hyperhomocysteinemia and hypertrophy  Shaiba Sana Qureshi, Ahsas Goyal  Journal of Indian.
Fatty acids, inflammation, and asthma
Macrophage heterogeneity, phenotypes, and roles in renal fibrosis
Pyroptosis Current Biology
Metabolic control of regulatory T cell development and function
Richard L. Gallo, Jamie J. Bernard 
EGFR signaling in renal fibrosis
Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells
The Stromal Intervention: Regulation of Immunity and Inflammation at the Epithelial- Mesenchymal Barrier  Roni Nowarski, Ruaidhrí Jackson, Richard A. Flavell 
Efren Rael, MD, FAAAAI  Journal of Allergy and Clinical Immunology 
Immune modulation by neuronal electric shock waves
Volume 146, Issue 7, Pages (June 2014)
S. Van Biervliet, J.P. Van Biervliet, E. Robberecht, A. Christophe 
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Mitochondria in the Regulation of Innate and Adaptive Immunity
The genetics of alcohol dependence and alcohol-related liver disease
Inflammasome Activation: How Macrophages Watch What They Eat
Herbert Tilg, Gökhan S. Hotamisligil  Gastroenterology 
Inflammation and Lipid Signaling in the Etiology of Insulin Resistance
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Lipid mediators in immune dysfunction after severe inflammation
Death receptor-mediated apoptosis and the liver
Rhiannon M. Kelsh, Paula J. McKeown-Longo, Richard A.F. Clark 
Daniel J. Rader, Ellen Puré  Cell Metabolism 
Update on the role of prostaglandins in allergic lung inflammation: Separating friends from foes, harder than you might think  Martin L. Moore, PhD, R.
Lipids in Liver Disease: Looking Beyond Steatosis
CD4+ T cells: a potential player in renal fibrosis
The eosinophil—quo vadis?
Molecular Mechanisms Underlying Cardiac Adaptation to Exercise
Fig. 1. Summary of AERD associated single nucleotide polymorphisms in the genes of immune response and arachidonate pathway. OR, odds ratio; Ref, reference.
Sachin K. Samuchiwal, PhD, Joshua A. Boyce, MD 
Subodh Verma, MD, PhD, Milan Gupta, MD, Paul M. Ridker, MD 
Volume 70, Issue 2, Pages (July 2006)
Figure 1.Metabolic formation of EPA and DHA and their conversion to anti-inflammatory and pro-resolving metabolites with chemopreventive and therapeutic.
Interstitial fibrosis: tubular hypothesis versus glomerular hypothesis
Renoprotection with vitamin D: Specific for diabetic nephropathy?
Aspirin therapy inhibits NLRP1 (nucleotide-binding domain-like receptor protein 1) inflammasome gene expression in patients with peripheral artery disease 
Predicting Risk of Radiation-Induced Lung Injury
Presentation transcript:

Cardioprotective mechanism of omega-3 polyunsaturated fatty acids Jin Endo, MD, PhD, Makoto Arita, PhD  Journal of Cardiology  Volume 67, Issue 1, Pages 22-27 (January 2016) DOI: 10.1016/j.jjcc.2015.08.002 Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 1 The proposed molecular mechanism of cardioprotection by omega-3 PUFAs. Omega-3 PUFAs modulate cell membrane property when incorporated into the phospholipid bilayer and control membrane ion channels to prevent lethal arrhythmia. Also omega-3 PUFAs exert anti-inflammatory and anti-fibrotic effects by modifying NF-κB signaling, the NLRP3 inflammasome, PPARα/γ, GPR120, and TGF-β signaling. NF-κB: nuclear factor-κB; NLRP3: NOD-like receptor family, pyrin domain containing 3; PPARα/γ: peroxisome proliferator-activated receptor α/γ; GPR120: G protein-coupled receptor 120; TGF-β: transforming growth factor-β. Journal of Cardiology 2016 67, 22-27DOI: (10.1016/j.jjcc.2015.08.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 2 Anti-inflammatory effects of omega-3 PUFAs through mediator balance. The anti-inflammatory effects of omega-3 PUFAs are attributed to (1) prevention of the conversion of AA into PGs and LTs or (2) its ability to function as an alternative substrate to produce less potent mediators. (3) Resolvins, protectins, and maresins, distinct anti-inflammatory and pro-resolving lipid mediators derived from omega-3 PUFAs. AA: arachidonic acid; PGs: prostaglandins; LTs: leukotrienes. Journal of Cardiology 2016 67, 22-27DOI: (10.1016/j.jjcc.2015.08.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions

Fig. 3 An EPA metabolite, 18-HEPE, from cardiac macrophages rich in omega-3 PUFAs prevents cardiac remodeling under pressure overload. Activated cardiac fibroblasts, namely myofibroblasts, produce pro-inflammatory mediators that facilitate cardiac macrophage activation. Cardiac fibroblasts can be activated directly by pressure overload or secondarily by inflammatory mediators released from activated inflammatory cells. EPA-enriched macrophages generate an 18-HEPE-rich milieu in the heart, thereby discontinue the profibrotic feed-forward loop that is involved in the development of cardiac fibrosis under pressure overload. EPA: eicosapentaenoic acid; 18-HEPE: 18-hydroxy eicosapentaenoic acid. Journal of Cardiology 2016 67, 22-27DOI: (10.1016/j.jjcc.2015.08.002) Copyright © 2015 Japanese College of Cardiology Terms and Conditions